Growth factors and human pituitary adenomas

Molecular and Cellular Endocrinology

Volumn 197, Issue 1-2, 2002, Pages 63-68

  Spada, Anna ^a   Lania, Andrea ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

GPCR; Growth factors; Pituitary adenomas

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; METHIONINE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; PROTEIN P16; PROTEIN P27; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; GROWTH PROMOTOR; ONCOPROTEIN; RAS PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HYPOPHYSIS ADENOMA; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTO ONCOGENE; RETINOBLASTOMA; REVIEW; TUMOR SUPPRESSOR GENE; ADENOMA; ANIMAL; GENETICS; HYPOPHYSIS TUMOR; METABOLISM;

ADENOMA; ANIMALS; GENES, TUMOR SUPPRESSOR; GROWTH SUBSTANCES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; ONCOGENE PROTEINS; PITUITARY NEOPLASMS; PROTEIN KINASE C; RAS PROTEINS;

EID: 0037195512     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00279-4     Document Type: Review

References (38)

1. Acks T., Fazeli A., Schmitt E.M. Effects of an RB mutation in the mouse. Nature. 359:1992;295-300.
2. Adams E.F., Brockmeier S., Friedmann E., Roth M., Buchfelder M., Fahlbusch R. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp negative pituitary tumors. Neurosurgery. 33:1993;198-203.
3. Alexander J.M., Biller B.M.K., Bikkal H., Zervas N.T., Arnold A., Klibanski A. Clinically non functioning pituitary adenomas are monoclonal in origin. J. Clin. Invest. 86:1990;336-340.
4. Alvaro V., Levy L., Dubray C., Roche A., Peillon F., Querat B., Joubert D. Invasive human pituitary tumors express a point-mutated alpha-protein kinase C. J. Clin. Endocrinol. Metab. 77:1993;1125-1129.
5. Asa S., Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr. Rev. 1:1998;798-827.
6. Ballare E., Mantovani S., Lania A., Di Blasio A.M., Vallar L., Spada A. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. J. Clin. Endocrinol. Metab. 83:1998;4386-4390.
7. Dahia P.L.M., Grossman A.B. The molecular pathogenesisi of corticotroph tumors. Endocr. Rev. 20:1999;136-155.
8. Fagin J.A., Pixley S., Slamina S., Ong J., Melmed S. Insulin.like growth factor I gene expression in GH3 rat pituitary cells;mRNA content, immunocytochemistry and secretion. Endocrinology. 120:1987;2037-2043.
9. Farrell W.E., Clayton R.N. Molecular genetics of pituitary tumours. Trends Endocrinol. Metab. 9:1998;20-26.
10. Gonsky R., Herman V., Melmed S., Fagin J. Transforming DNA sequences present in human prolactin-secreting tumors. Mol. Endocrinol. 5:1991;1687-1695.
11. Gupta S.K., Gallego C., Lowndes J.M., Pleiman C.M., Sable C., Eisfelder B.J. Analysis of the fibroblast transformation potential of GTPase deficient gip2 oncogenes. Mol. Cell. Biol. 12:1992;190-195.
12. Itakura M. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN-1 gene in sporadic pituitary adenomas. J. Clin. Endocrinol. Metab. 83:1998;2631-2634.
13. Karga H.J., Alexander J.M., Hedley C., Scheithauer B.W., Whyte E.T., Jameson J. Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab. 74:1992;914-919.
14. Landis C., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 340:1989;692-696.
15. Lania A., Persani L., Ballare E., Mantovani S., Losa M., Spada A. Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J. Clin. Endocrinol. Metab. 83:1998;1624-1628.
16. LeRiche V.K., Asa S.L., Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J. Clin. Endocrinol. Metab. 81:1996;656-662.
17. Levy A., Hall L., Yeudall W.A., Lightman S.L. p53 gene mutations in pituitary adenomas: rare events. Clin. Endocrinol. 41:1994;809-814.
18. Lyons J., Landis C.A., Harsh G., Vallar L., Grunwald K., Feichtinger H., Bourne H. Two G protein oncogenes in human endocrine tumors. Science. 249:1990;655-659.
19. Missale C., Losa M., Sigala S., Balsari A., Giovanelli M., Spano P.F. Nerve growth factor controls proliferation and progression of human prlactinoma cell lines through an autocrine mechanism. Mol. Endocrinol. 19:1996;272-285.
20. McAndrew J., Peterson A.J., Asa S.L., McCarthy K.L., Kudlow J.E. Targeting of transforming growth factor alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology. 136:1995;4479-4488.
21. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Hori I., Loh D.Y. Mice lacking p27(kip1) display incraesed body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumours. Cell. 87:1996;707-720.
22. O'Sullivan C., Barton C.M., Staddon S.L., Brown C.L., Lemoine N.R. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol. Carcinog. 4:1991;345-349.
23. Penabad J.L., Bashey H.M., Asa S.L., Haddad G., Davis K.D., Herbst A.B., Kaiser U.B., Chin W.W., Snyder P.J. Decreased follistatin gene expression in gonadotroph adenomas. J. Clin. Endocrinol. Metab. 81:1996;3397-3403.
24. Peri A., Conforti B., Baglioni-Peri S., Luciani P., Cioppi F., Buci L., Corbetta S., Ballarè E., Serio M., Spada A. Expression of cAMP responsive element binding protein and inducible cAMP early repressor genes in growth hormone secreting pituitary adenomas with or without mutations of the Gsα gene. J. Clin. Endocrinol. Metab. 86:2001;2111-2117.
25. Persani L., Lania A., Alberti L., Romoli R., Mantovani G., Filetti S., Spada A., Conti M. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. J. Clin. Endocrinol. Metab. 85:2000;2872-2878.
26. Ray D., Melmed S. Pituitary cytokine and growth factor expression and action. Endocr. Rev. 18:1997;206-228.
27. Schiemann U., Assert R., Moskopp D., Gellner R., Hengst K., Gullotta F., Domschke W., Pfeiffer A. Analysis of a protein kinase C.-α mutation in human pituitary tumours. J. Endocrinol. 53:1997;131-137.
28. Shen Y., Mamers P., Jobling T., Burger G.H., Fuller P.J. Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab. 81:1996;4159-4161.
29. Shimon I., Melmed S. Genetic basis of endocrine disease: pituitary tumour pathogenesis. J. Clin. Endocrinol. Metab. 82:1997;1675-1681.
30. Spada A., Arosio M., Bochicchio D., Bazzoni N., Vallar L., Bassetti M., Faglia G. Clinical, biochemical and morphological correlates in patients bearing growth hormone secreting tumors with or without constitutively active adenylyl cyclase. J. Clin. Endocrinol. Metab. 71:1990;1421-1426.
31. Spada A., Lania A., Ballare E. G protein abnormalities in pituitary adenomas. Mol. Cell. Endocrinol. 142:1998;1-14.
32. Suarez H.G., du Villard J.A., Caillou B., Schlumberger M., Parmentier C., Monier R. gsp mutations in human thyroid tumours. Oncogene. 6:1991;677-679.
33. Tanaka C., Kimura T., Yang P., Moritani M., Yamaoka T., Yamada S., Sano T., Yoshimoto K., Zhang X., Horwitz G.A., Heaney A.P., Nakashima M., Prezant T.R., Bronstein M.D., Melmed S. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J. Clin. Endocrinol. Metab. 84:1999;761-767.
34. van Wijk P.A., van Neck J.W., Rijnberk A., Croughs R.J.M., Mol J.A. Proliferation of murine corticotropic tumor cell line AtT20 is affected by hypophysiotropic hormones. Growth factors and glucocorticoids. Mol. Cell. Endocrinol. 111:1995;13-19.
35. Weinstein L.S., Shenker A., Gejman P., Marino M.J., Friedman E., Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl. J. Med. 325:1991;1688-1695.
36. Williamson E.A., Daniels M., Foster S., Kelly W.F., Kendall-Taylor P., Harris P.E. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours. Clin. Endocrinol. (Oxf.). 41:1994;815-820.
37. Woloschak M., Yu A.Q., Xiao J.Q., Post K.D. Frequent loss of the p16ink4a in human pituitary tumors. Cancer Res. 56:1996;2493-2496.
38. Zimering M.B., Katsumata N., Sato Y., Brandi M.L., Aubach G.D., Marx S.J., Friesen H.G. Increased basic fibroblast groth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J. Clin. Endocrinol. Metab. 76:1993;1182-1187.